186 related articles for article (PubMed ID: 36000536)
21. The PI3K/AKT/mTOR pathway is activated in gastric cancer with potential prognostic and predictive significance.
Tapia O; Riquelme I; Leal P; Sandoval A; Aedo S; Weber H; Letelier P; Bellolio E; Villaseca M; Garcia P; Roa JC
Virchows Arch; 2014 Jul; 465(1):25-33. PubMed ID: 24844205
[TBL] [Abstract][Full Text] [Related]
22. Bufalin targeting BFAR inhibits the occurrence and metastasis of gastric cancer through PI3K/AKT/mTOR signal pathway.
Chen G; Zhang H; Sun H; Ding X; Liu G; Yang F; Feng G; Dong X; Zhu Y; Wang X; Wang Y; Li B; Yang L
Apoptosis; 2023 Oct; 28(9-10):1390-1405. PubMed ID: 37253905
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of SRSF3 Alleviates Proliferation and Migration of Gastric Cancer Cells by Regulating the PI3K/AKT/mTOR Signalling Pathway.
Xie J; Sun Y; Xu Q
Folia Biol (Praha); 2021; 67(3):102-107. PubMed ID: 35151243
[TBL] [Abstract][Full Text] [Related]
24. HOXB13 promotes gastric cancer cell migration and invasion via IGF-1R upregulation and subsequent activation of PI3K/AKT/mTOR signaling pathway.
Guo C; Chu H; Gong Z; Zhang B; Li C; Chen J; Huang L
Life Sci; 2021 Aug; 278():119522. PubMed ID: 33894267
[TBL] [Abstract][Full Text] [Related]
25. Down-regulated lncRNA SLC25A5-AS1 facilitates cell growth and inhibits apoptosis via miR-19a-3p/PTEN/PI3K/AKT signalling pathway in gastric cancer.
Li X; Yan X; Wang F; Yang Q; Luo X; Kong J; Ju S
J Cell Mol Med; 2019 Apr; 23(4):2920-2932. PubMed ID: 30793479
[TBL] [Abstract][Full Text] [Related]
26. The FOXO1/G6PC axis promotes gastric cancer progression and mediates 5-fluorouracil resistance by targeting the PI3K/AKT/mTOR signaling pathway.
Han A; Liu T; Du P; Wang M; Liu J; Chen L
Mol Carcinog; 2024 Apr; 63(4):688-700. PubMed ID: 38224261
[TBL] [Abstract][Full Text] [Related]
27. The Gene Expression Status of the PI3K/AKT/mTOR Pathway in Gastric Cancer Tissues and Cell Lines.
Riquelme I; Tapia O; Espinoza JA; Leal P; Buchegger K; Sandoval A; Bizama C; Araya JC; Peek RM; Roa JC
Pathol Oncol Res; 2016 Oct; 22(4):797-805. PubMed ID: 27156070
[TBL] [Abstract][Full Text] [Related]
28. Effect of COP1 in Promoting the Tumorigenesis of Gastric Cancer by Down-Regulation of CDH18 via PI3K/AKT Signal Pathway.
Zhao B; Wu J; Cha X; Mao G; Shi H; Fei S; Miao B
Anal Cell Pathol (Amst); 2023; 2023():5617875. PubMed ID: 37025097
[TBL] [Abstract][Full Text] [Related]
29. Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination.
Yu JS; Cui W
Development; 2016 Sep; 143(17):3050-60. PubMed ID: 27578176
[TBL] [Abstract][Full Text] [Related]
30. FGFR2 Promotes Gastric Cancer Progression by Inhibiting the Expression of Thrombospondin4 via PI3K-Akt-Mtor Pathway.
Huang T; Liu D; Wang Y; Li P; Sun L; Xiong H; Dai Y; Zou M; Yuan X; Qiu H
Cell Physiol Biochem; 2018; 50(4):1332-1345. PubMed ID: 30355943
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of TYRO3 indicates poor prognosis and induces gastric cancer progression via AKT-mTOR pathway.
Wang J; Cheng Z; Dai D; Li H; Shao X; Xu M
Mol Carcinog; 2023 Sep; 62(9):1325-1337. PubMed ID: 37212497
[TBL] [Abstract][Full Text] [Related]
32. A miR-567-PIK3AP1-PI3K/AKT-c-Myc feedback loop regulates tumour growth and chemoresistance in gastric cancer.
Zhang F; Li K; Yao X; Wang H; Li W; Wu J; Li M; Zhou R; Xu L; Zhao L
EBioMedicine; 2019 Jun; 44():311-321. PubMed ID: 31078520
[TBL] [Abstract][Full Text] [Related]
33. Alpha1-ACT Functions as a Tumour Suppressor in Hepatocellular Carcinoma by Inhibiting the PI3K/AKT/mTOR Signalling Pathway via Activation of PTEN.
Zhu H; Liu Q; Tang J; Xie Y; Xu X; Huang R; Zhang Y; Jin K; Sun B
Cell Physiol Biochem; 2017; 41(6):2289-2306. PubMed ID: 28456796
[TBL] [Abstract][Full Text] [Related]
34. CLDN4 silencing promotes proliferation and reduces chemotherapy sensitivity of gastric cancer cells through activation of the PI3K/Akt signalling pathway.
Luo J; Wang H; Chen H; Gan G; Zheng Y
Exp Physiol; 2020 Jun; 105(6):979-988. PubMed ID: 31856376
[TBL] [Abstract][Full Text] [Related]
35. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors.
Smit DJ; Cayrefourcq L; Haider MT; Hinz N; Pantel K; Alix-Panabières C; Jücker M
Cells; 2020 Sep; 9(9):. PubMed ID: 32962206
[TBL] [Abstract][Full Text] [Related]
36. The adenosine-A2a receptor regulates the radioresistance of gastric cancer via PI3K-AKT-mTOR pathway.
Liu G; Yang S; Liu Y; Xu Y; Qiu H; Sun J; Song J; Shi L
Int J Clin Oncol; 2022 May; 27(5):911-920. PubMed ID: 35122587
[TBL] [Abstract][Full Text] [Related]
37. Pyrroline-5-Carboxylate Reductase-2 Promotes Colorectal Cancer Progression via Activating PI3K/AKT/mTOR Pathway.
Yin F; Huang X; Xuan Y
Dis Markers; 2021; 2021():9950663. PubMed ID: 34512817
[TBL] [Abstract][Full Text] [Related]
38. HDAC3-mediated lncRNA-LOC101928316 contributes to cisplatin resistance in gastric cancer via activating the PI3K-Akt-mTOR pathway.
Ren H; Tang L
Neoplasma; 2021 Sep; 68(5):1043-1051. PubMed ID: 34427099
[TBL] [Abstract][Full Text] [Related]
39. Thymoquinone induces cytotoxicity and reprogramming of EMT in gastric cancer cells by targeting PI3K/Akt/mTOR pathway.
Feng LM; Wang XF; Huang QX
J Biosci; 2017 Dec; 42(4):547-554. PubMed ID: 29229873
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA‑495 regulates human gastric cancer cell apoptosis and migration through Akt and mTOR signaling.
Wang J; Feng W; Dong Y; Mao X; Guo F; Luo F
Oncol Rep; 2018 Dec; 40(6):3654-3662. PubMed ID: 30272336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
